This section hosts guidelines, manuals and toolkits to strengthen public health practice.
Pre-exposure prophylaxis, or PrEP, is a way to help HIV-negative people protect themselves from contracting HIV. PrEP involves the use of antiretroviral drugs to reduce the risk of becoming infected with HIV. In 2020, the WHO published the results from a study of a long-acting drug for PrEP that show it to be ‘highly effective’ in preventing HIV acquisition in adult men who have sex with men and transgender women. PrEP Watch is an online repository for the latest PrEP data, research, cost, access, implementation, and advocacy efforts across the globe. This particular set of resources on PrEP Watch is tailored exclusively for the Indian context. The resources include a complete list of research, demonstration, and implementation projects; and a framework for scaling up PrEP programs. These tools are specifically designed for implementing organizations.
To access this click here.
How can psychosocial interventions be designed to reduce HIV risk for MSM?
by Matthew J. Mimiaga, ... 60 min read